In order to determine if PD1 was required in vivo for the development of hyporesponsiveness, mice were administered anti-PD1 MAb throughout the infection process, and the proliferation of CD4+ T cells was determined in vivo by the uptake of BrdU (Fig. 3E). Here, CD4 is linked to infection.